Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
- May -
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
- 2011 -
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
May 2011 - 70 products
IP
CI
Paracetamol-Mepha 500 mg
300
PR
PR
k.A.
Coated tablets: Paracetamolum 500 mg
Mepha Pharma AG
B
FB
G
IP
CI
Repaglinide Rivopharm 0.5 mg
PR
PR
k.A.
Tablets: Repaglinidum
Rivopharm SA
FB
G
IP
CI
Repaglinide Rivopharm 1 mg
PR
PR
k.A.
Tablets: Repaglinidum 1 mg
Rivopharm SA
FB
G
IP
CI
Repaglinide Rivopharm 2 mg
PR
PR
k.A.
Tablets: Repaglinidum 2 mg
Rivopharm SA
FB
G
L
IP
CI
Sevikar HCT 20 mg/5
mg/12.5 mg
28 Tablet(s)
20.81
40.35
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 20 mg/5
mg/12.5 mg
98 Tablet(s)
59.42
84.70
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5
mg/12.5 mg
28 Tablet(s)
25.73
46.00
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5
mg/12.5 mg
98 Tablet(s)
74.05
101.50
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/12.5 mg
28 Tablet(s)
26.83
47.25
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/12.5 mg
98 Tablet(s)
81.25
109.80
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5 mg/25 mg
28 Tablet(s)
25.73
46.00
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/5 mg/25 mg
98 Tablet(s)
74.05
101.50
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/25 mg
28 Tablet(s)
26.83
47.25
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
L
IP
CI
Sevikar HCT 40 mg/10
mg/25 mg
98 Tablet(s)
81.25
109.80
20 %
Coated tablets: 3 Active Agents
Daiichi Sankyo
(Schweiz) AG
B / SL / SO
FB
G
IP
CI
Zolmitriptan-Mepha oro
3 Tablet(s)
10.14
19.85
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan-Mepha oro
6 Tablet(s)
19.40
38.70
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Zolmitriptan-Mepha oro
12 Tablet(s)
34.04
55.55
10 %
Melting tablets: Zolmitriptanum 2.5 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 10 mg
30
13.04
27.30
10 %
Coated tablets: Atorvastatinum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 10 mg
100
42.88
65.70
10 %
Coated tablets: Atorvastatinum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 20 mg
30
13.04
27.30
10 %
Coated tablets: Atorvastatinum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 20 mg
100
42.88
65.70
10 %
Coated tablets: Atorvastatinum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 40 mg
30
13.04
27.30
10 %
Coated tablets: Atorvastatinum 40 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 40 mg
100
42.88
65.70
10 %
Coated tablets: Atorvastatinum 40 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 80 mg
30
13.04
27.30
10 %
Coated tablets: Atorvastatinum 80 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Atorvastatin Sandoz 80 mg
100
42.88
65.70
10 %
Coated tablets: Atorvastatinum 80 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Letrozol Zentiva
30
54.89
79.50
10 %
Coated tablets: Letrozolum 2.5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Letrozol Zentiva
100
182.09
225.65
10 %
Coated tablets: Letrozolum 2.5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 250 mg
20 Tablet(s)
3.10
7.65
10 %
Coated tablets: Metronidazolum 250 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
4 Tablet(s)
1.22
5.50
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva 500 mg
20 Tablet(s)
5.43
14.45
10 %
Coated tablets: Metronidazolum 500 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 10 mg
14 Tablet(s)
5.49
14.50
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 10 mg
28 Tablet(s)
9.68
19.35
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 10 mg
56 Tablet(s)
20.30
39.75
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 10 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 20 mg
7 Tablet(s)
5.12
14.10
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 20 mg
14 Tablet(s)
9.01
18.55
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 20 mg
28 Tablet(s)
17.24
36.25
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rabeprazol Sandoz 20 mg
56 Tablet(s)
34.97
56.60
10 %
Gastric juice resistant tablets: Rabeprazolum Natricum 20 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Repaglinide Rivopharm 0.5 mg
90
8.39
17.85
10 %
Tablets: Repaglinidum
Rivopharm SA
B / SL / SG
FB
G
L
IP
CI
Repaglinide Rivopharm 1 mg
90
10.16
19.90
10 %
Tablets: Repaglinidum 1 mg
Rivopharm SA
B / SL / SG
FB
G
L
IP
CI
Repaglinide Rivopharm 2 mg
90
11.90
26.00
10 %
Tablets: Repaglinidum 2 mg
Rivopharm SA
B / SL / SG
FB
G
IP
CI
CM
Metronidazole Zentiva
10 suppositories
5.16
14.15
10 %
Vaginal ovules: Metronidazolum 500 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
PP
Halaven
Durchstechflasche(n)
225.64
275.70
10 %
Injection solution: Eribulini Mesilas 1 mg
Eisai Pharma AG
A / SL
FB
G
IP
CI
Paracetamol-Mepha 500 mg
20
1.30
2.40
10 %
Coated tablets: Paracetamolum 500 mg
Mepha Pharma AG
● 
D / SL
FB
G
IP
CI
Paracetamol-Mepha 500 mg
100
5.60
14.65
10 %
Coated tablets: Paracetamolum 500 mg
Mepha Pharma AG
B / SL
FB
G
IP
CI
Paracetamol-Mepha 500 mg
100
5.60
14.65
10 %
Coated tablets: Paracetamolum 500 mg
Mepha Pharma AG
● 
B / SL
FB
G
IP
CI
Vimovo
30 Tablet(s)
10.75
20.55
10 %
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B / SL
FB
G
IP
CI
Vimovo
30
10.75
20.55
10 %
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B / SL
FB
G
IP
CI
Vimovo
60 Tablet(s)
21.50
41.10
10 %
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B / SL
FB
G
IP
CI
Vimovo
60
21.50
41.10
10 %
Coated tablets: 2 Active Agents
Grünenthal Pharma AG
B / SL
FB
G
L
IP
CI
Votubia 2.5 mg
30 Tablet(s)
1138.75
1311.70
10 %
Tablets: Everolimusum 2.5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
L
IP
CI
Votubia 5 mg
30 Tablet(s)
2202.22
2479.20
10 %
Tablets: Everolimusum 5 mg
Novartis Pharma
Schweiz AG
A / SL
FB
G
IP
CI
Natecal D
60 Tablet(s)
7.09
13.10
10 %
comprimé orodispersible: 2 Active Agents
Effik SA
● 
D / SL
FB
G
IP
CI
Natecal D
120 Tablet(s)
12.48
23.05
10 %
comprimé orodispersible: 2 Active Agents
Effik SA
D / SL
FB
G
IP
CI
Budenofalk Uno 9 mg
20 Sachet(s)
60.39
85.80
10 %
magensaftresistentes Granulat: Budesonidum 9 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
CI
Budenofalk Uno 9 mg
60 Sachet(s)
180.62
223.95
10 %
magensaftresistentes Granulat: Budesonidum 9 mg
Dr. Falk Pharma AG
B / SL
FB
G
IP
Levex i.v. 250
10 x 50 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 250mg / 50ml
Lagap SA
A
FB
G
IP
Levex i.v. 500
10 x 100 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 500mg / 100ml
Lagap SA
A
FB
G
IP
Levex i.v. 250
24 x 50 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 250mg / 50ml
Lagap SA
A
FB
G
IP
Levex i.v. 500
24 x 100 ml
PR
PR
k.A.
Infusion solution: Levofloxacinum 500mg / 100ml
Lagap SA
A
FB
G
IP
CI
Zolmitriptan-Mepha oro
2 Tablet(s)
PR
PR
k.A.
Melting tablets: Zolmitriptanum 2.5 mg
Mepha Pharma AG
B
FB
G
IP
CI
Atorvastatin Sandoz 10 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 10 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 10 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 20 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 20 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 20 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 40 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 40 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 40 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 40 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 80 mg
30
PR
PR
k.A.
Coated tablets: Atorvastatinum 80 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Atorvastatin Sandoz 80 mg
100
PR
PR
k.A.
Coated tablets: Atorvastatinum 80 mg
Sandoz
Pharmaceuticals AG
B
FB
G
CI
H
Similasan Entzündete
Augen, Augentropfen 10 ml
10 ml
PR
PR
k.A.
Solution: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
CI
H
Similasan Überanstrengte
Augen, Augentropfen 10 ml
10 ml
PR
PR
k.A.
Solution: 3 Active Agents
T&S Eye Care
Management AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2024
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home